Briacell Therapeutics Corp reports results for the quarter ended in July - Earnings Summary

Briacell Therapeutics

26/10/2023 24:34

* Briacell Therapeutics Corp  BCT.TO  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
July. The mean expectation of two analysts for the quarter was
for a loss of 40 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Briacell Therapeutics Corp's reported EPS for the quarter
was a
loss of 14 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Briacell Therapeutics Corp shares had fallen by 19.4% this
quarter and gained 16.0% so far this year.
    * The company reported a quarterly loss of $2.42 million.
    * Wall Street's median 12-month price target for Briacell
Therapeutics Corp is $15.00 

This summary was machine generated from LSEG Refinitiv data
October 25 at 11:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jul. 31 2023      -0.40          -0.14          Beat
 Apr. 30 2023      -0.35          -0.32          Beat
 Jan. 31 2023      -0.35          -0.77          Missed
 Oct. 31 2022      -0.33          -0.07          Beat